Titan Pharmaceuticals, Inc. (TTNP) earnings
TTNP earnings moved a median of -0.30% by the close. Quarterly and annual TTNP reports and results, each read against the price at its own news timestamp. Back to the TTNP overview →
10 measured TTNP earnings events.
Where these TTNP earnings landedvs 10 measured TTNP earnings reactions
| Middle 50% of TTNP earnings reactions | -2.57% to +3.59% |
|---|---|
| Median reaction (to close) | -0.30% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 TTNP earnings events with a measured close landed between -2.57% and +3.59%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | — | -1.40% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +8.14% | +4.07% | |
| Form 10-K TITAN PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | — | +15.75% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +3.71% | +2.17% | |
| Form NT 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form NT | +0.00% | -2.13% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | — | -2.71% | |
| Form NT 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form NT | — | -2.71% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -1.55% | +0.79% | |
| Form 10-K TITAN PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | — | +4.21% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.06% |
Keep exploring
More TTNP: analyst actions → · SEC filings → · TTNP overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ASTELLAS PHARMA UNSP/ADR (ALPMY) | 94 | +0.02% | 50% |
| Check-Cap Ltd. - Ordinary Share (CHEK) | 94 | -0.11% | 42% |
| COGNETIVITY NEUROSCIENCES (CGNSF) | 93 | 0.00% | 37% |
| ENZON PHARMS INC (ENZN) | 93 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.